These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 8878602)
1. Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis. Larsen RA; Bauer M; Weiner JM; Diamond DM; Leal ME; Ding JC; Rinaldi MG; Graybill JR Antimicrob Agents Chemother; 1996 Sep; 40(9):2178-82. PubMed ID: 8878602 [TBL] [Abstract][Full Text] [Related]
2. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis. Larsen RA; Bauer M; Thomas AM; Graybill JR Antimicrob Agents Chemother; 2004 Mar; 48(3):985-91. PubMed ID: 14982793 [TBL] [Abstract][Full Text] [Related]
3. Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis. Nguyen MH; Najvar LK; Yu CY; Graybill JR Antimicrob Agents Chemother; 1997 May; 41(5):1120-3. PubMed ID: 9145879 [TBL] [Abstract][Full Text] [Related]
4. Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitis. Diamond DM; Bauer M; Daniel BE; Leal MA; Johnson D; Williams BK; Thomas AM; Ding JC; Najvar L; Graybill JR; Larsen RA Antimicrob Agents Chemother; 1998 Mar; 42(3):528-33. PubMed ID: 9517927 [TBL] [Abstract][Full Text] [Related]
5. Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis. Ding JC; Bauer M; Diamond DM; Leal MA; Johnson D; Williams BK; Thomas AM; Najvar L; Graybill JR; Larsen RA Antimicrob Agents Chemother; 1997 Jul; 41(7):1589-93. PubMed ID: 9210691 [TBL] [Abstract][Full Text] [Related]
6. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. Nussbaum JC; Jackson A; Namarika D; Phulusa J; Kenala J; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; Kamwendo D; van der Horst CM; Harrison TS Clin Infect Dis; 2010 Feb; 50(3):338-44. PubMed ID: 20038244 [TBL] [Abstract][Full Text] [Related]
7. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model. Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852 [TBL] [Abstract][Full Text] [Related]
8. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774 [TBL] [Abstract][Full Text] [Related]
9. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial. Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259 [TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome. Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075 [TBL] [Abstract][Full Text] [Related]
11. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS. Jaruratanasirikul S Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873 [TBL] [Abstract][Full Text] [Related]
12. Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis. Milefchik E; Leal MA; Haubrich R; Bozzette SA; Tilles JG; Leedom JM; McCutchan JA; Larsen RA Med Mycol; 2008 Jun; 46(4):393-5. PubMed ID: 18415850 [TBL] [Abstract][Full Text] [Related]
13. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387 [TBL] [Abstract][Full Text] [Related]
14. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: A retrospective cohort study. Li Z; Liu Y; Chong Y; Li X; Jie Y; Zheng X; Yan Y Mycoses; 2019 Aug; 62(8):686-691. PubMed ID: 31120606 [TBL] [Abstract][Full Text] [Related]
15. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Sloan D; Dlamini S; Paul N; Dedicoat M Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697 [TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients. Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835 [TBL] [Abstract][Full Text] [Related]
17. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries. Loyse A; Burry J; Cohn J; Ford N; Chiller T; Ribeiro I; Koulla-Shiro S; Mghamba J; Ramadhani A; Nyirenda R; Aliyu SH; Wilson D; Le T; Oladele R; Lesikari S; Muzoora C; Kalata N; Temfack E; Mapoure Y; Sini V; Chanda D; Shimwela M; Lakhi S; Ngoma J; Gondwe-Chunda L; Perfect C; Shroufi A; Andrieux-Meyer I; Chan A; Schutz C; Hosseinipour M; Van der Horst C; Klausner JD; Boulware DR; Heyderman R; Lalloo D; Day J; Jarvis JN; Rodrigues M; Jaffar S; Denning D; Migone C; Doherty M; Lortholary O; Dromer F; Stack M; Molloy SF; Bicanic T; van Oosterhout J; Mwaba P; Kanyama C; Kouanfack C; Mfinanga S; Govender N; Harrison TS Lancet Infect Dis; 2019 Apr; 19(4):e143-e147. PubMed ID: 30344084 [TBL] [Abstract][Full Text] [Related]
18. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426 [TBL] [Abstract][Full Text] [Related]